Cargando…

Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease

BACKGROUND: Asymmetric hemispheric loss of dopaminergic neurons is one of the characteristic features of Parkinson's disease (PD). However, it is still debated if right or left asymmetry differently affects cognitive and motor progression. OBJECTIVES: The objective of this study was to investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorenzato, Eleonora, Antonini, Angelo, Bisiacchi, Patrizia, Weis, Luca, Biundo, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596815/
https://www.ncbi.nlm.nih.gov/pubmed/34124799
http://dx.doi.org/10.1002/mds.28682
_version_ 1784600471632084992
author Fiorenzato, Eleonora
Antonini, Angelo
Bisiacchi, Patrizia
Weis, Luca
Biundo, Roberta
author_facet Fiorenzato, Eleonora
Antonini, Angelo
Bisiacchi, Patrizia
Weis, Luca
Biundo, Roberta
author_sort Fiorenzato, Eleonora
collection PubMed
description BACKGROUND: Asymmetric hemispheric loss of dopaminergic neurons is one of the characteristic features of Parkinson's disease (PD). However, it is still debated if right or left asymmetry differently affects cognitive and motor progression. OBJECTIVES: The objective of this study was to investigate, for the first time, the relevance of dopamine transporter (DAT) asymmetry on cognitive and motor manifestations at onset and at 4‐year progression in drug‐naïve PD. METHODS: From the Parkinson's Progression Markers Initiative multicenter cohort, we identified 249 right‐handed patients with PD with baseline asymmetry greater than 20% in putamen DAT binding at single‐photon emission computed tomography. A predominant putamen asymmetry was found on the left in 143 patients (PD‐left), and on the right side in 106 patients (PD‐right); we compared them with 196 healthy controls. Patients were followed longitudinally (2‐year and 4‐year visits), examining their clinical, cognitive, and imaging data. RESULTS: At baseline, the PD‐left group showed worse performance on the Symbol Digit Modality Test, an attention and processing‐speed test, and lower cerebrospinal fluid β‐amyloid levels than the PD‐right group. These differences were maintained at follow‐up, declining over time in both groups. By contrast, the PD‐right group showed greater motor impairment at baseline, which increased over 4 years. Striatal DAT binding decreased over time in both groups, but the PD‐right group showed a steeper decline, particularly during the first 2‐year follow‐up. Putaminal asymmetry assessed at baseline was maintained over time. CONCLUSIONS: These findings suggest that hemispheric asymmetric dopaminergic denervation influences PD cognitive and motor performance as well as progression. Predominant right hemisphere nigrostriatal dopaminergic loss is associated with greater motor severity, whereas more pronounced left hemisphere denervation affects cognitive manifestations at onset and their progression. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society
format Online
Article
Text
id pubmed-8596815
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-85968152021-11-22 Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease Fiorenzato, Eleonora Antonini, Angelo Bisiacchi, Patrizia Weis, Luca Biundo, Roberta Mov Disord Regular Issue Articles BACKGROUND: Asymmetric hemispheric loss of dopaminergic neurons is one of the characteristic features of Parkinson's disease (PD). However, it is still debated if right or left asymmetry differently affects cognitive and motor progression. OBJECTIVES: The objective of this study was to investigate, for the first time, the relevance of dopamine transporter (DAT) asymmetry on cognitive and motor manifestations at onset and at 4‐year progression in drug‐naïve PD. METHODS: From the Parkinson's Progression Markers Initiative multicenter cohort, we identified 249 right‐handed patients with PD with baseline asymmetry greater than 20% in putamen DAT binding at single‐photon emission computed tomography. A predominant putamen asymmetry was found on the left in 143 patients (PD‐left), and on the right side in 106 patients (PD‐right); we compared them with 196 healthy controls. Patients were followed longitudinally (2‐year and 4‐year visits), examining their clinical, cognitive, and imaging data. RESULTS: At baseline, the PD‐left group showed worse performance on the Symbol Digit Modality Test, an attention and processing‐speed test, and lower cerebrospinal fluid β‐amyloid levels than the PD‐right group. These differences were maintained at follow‐up, declining over time in both groups. By contrast, the PD‐right group showed greater motor impairment at baseline, which increased over 4 years. Striatal DAT binding decreased over time in both groups, but the PD‐right group showed a steeper decline, particularly during the first 2‐year follow‐up. Putaminal asymmetry assessed at baseline was maintained over time. CONCLUSIONS: These findings suggest that hemispheric asymmetric dopaminergic denervation influences PD cognitive and motor performance as well as progression. Predominant right hemisphere nigrostriatal dopaminergic loss is associated with greater motor severity, whereas more pronounced left hemisphere denervation affects cognitive manifestations at onset and their progression. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society John Wiley & Sons, Inc. 2021-06-14 2021-10 /pmc/articles/PMC8596815/ /pubmed/34124799 http://dx.doi.org/10.1002/mds.28682 Text en © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Regular Issue Articles
Fiorenzato, Eleonora
Antonini, Angelo
Bisiacchi, Patrizia
Weis, Luca
Biundo, Roberta
Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
title Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
title_full Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
title_fullStr Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
title_full_unstemmed Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
title_short Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
title_sort asymmetric dopamine transporter loss affects cognitive and motor progression in parkinson's disease
topic Regular Issue Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596815/
https://www.ncbi.nlm.nih.gov/pubmed/34124799
http://dx.doi.org/10.1002/mds.28682
work_keys_str_mv AT fiorenzatoeleonora asymmetricdopaminetransporterlossaffectscognitiveandmotorprogressioninparkinsonsdisease
AT antoniniangelo asymmetricdopaminetransporterlossaffectscognitiveandmotorprogressioninparkinsonsdisease
AT bisiacchipatrizia asymmetricdopaminetransporterlossaffectscognitiveandmotorprogressioninparkinsonsdisease
AT weisluca asymmetricdopaminetransporterlossaffectscognitiveandmotorprogressioninparkinsonsdisease
AT biundoroberta asymmetricdopaminetransporterlossaffectscognitiveandmotorprogressioninparkinsonsdisease